menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Permanent Contraception: Utilizing Transvaginal Ultrasonography to Confirm Appropriate Insert Placement

TVU was approved as an in-office procedure and alternate confirmation test for permanent contraception microinserts.

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Of the 61 million women in the U.S. being of childbearing age, it is estimated that 43 million are at risk for unintended pregnancy. In 2002, the US FDA approved the first hysteroscopic sterilization device for female permanent contraception, a microinsert placed into the tubal lumen. Confirmation of placement and tubal occlusion is performed three months following insertion and has, in the past, required an invasive process. In July 2015, the FDA approved transvaginal ultrasound (TVU) as an in-office procedure and alternate confirmation test for permanent contraception microinserts as opposed to hospital-based, and which permits a faster return to routine activity for the patient.

    Join us as Dr. Hector Chapa and Laura Decker, a Certified Diagnostic Sonographer, discuss the emergent role that TVU plays in the confirmation of appropriate placement of permanent contraceptive microinserts, as well as an in-depth visual explanation of the confirmation process.

  • Disclosure of Conflicts of Interest

    Disclosure of Conflicts of Interest: 

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty: 

    Hector O. Chapa, MD
    Medical Director, Women's Speciality Center Dallas
    Clinical Faculty Methodist Dallas Medical Center
    Methodist Hospital Dallas Department of Ob/Gyn
    Dallas, TX

    Dr. Chapa receives consulting fees from and is a speaker for Bayer HealthCare.

    Laura Decker, BS, RDMS, MHA
    Practice Sonographer
    Basinski and Juran, MDs
    Newburgh, IN

    Ms. Decker has nothing to disclose.

    Reviewers/Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Viviane Connor, MD receives consulting fees from Bayer Healthcare.
    • Kia K. Gray, MPH has nothing to disclose.
    • Robert Schneider has nothing to disclose.
    • Jennifer Spear Smith, PhD has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Review the protocol for transvaginal ultrasound (TVU) to allow reliance on hysteroscopic sterilization with nitinol inserts
    • Understand the benefits and disadvantages of TVU in the confirmation process for microinsert placement
    • Enhance sonographer awareness of the availability of the training certification program for the confirmation of appropriate TVU insert placement, as requested by the FDA of the device manufacturer
  • Target Audience

    This activity is designed to meet the educational needs of sonographers and Ob/Gyn specialty sonographers.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

  • Commercial Support

    This activity is supported by an independent educational grant from Bayer HealthCare.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.